The global molecular cytogenetics market size is calculated at USD 2.78 billion in 2025 and is expected to reach around USD 6 ...
Researchers have created a novel imaging-technology combination that can capture gene activity in individual bacteria in ...
4h
The Brighterside of News on MSNHuman touch stimulates 16 different types of nerve cells in the bodyThe human sense of touch is a complex system that integrates diverse sensations such as pain, temperature, and pleasant ...
Enhertu (fam-trastuzumab deruxtecan-nxki) has received FDA approval for HR-positive, HER2-low, HER2-ultralow metastatic breast cancer.
Akia, the premier guest journey platform, announces new email and SMS marketing capabilities designed to maximize direct bookings. This Marketing Suite seamlessly integrates with leading property ...
Juvare®, the leader in situational awareness and critical incident preparedness and response technology, has been granted Impact Level 5 (IL5) Provisional Authorization (PA) from the U.S. Department ...
During a Case-Based Roundtable® event, Nitin Jain, MD, and participants discussed treating a patient with CLL after ...
Findings showed datopotamab deruxtecan reduced the risk of disease progression or death by 37% compared with chemotherapy.
The global in vitro diagnostics market size was reached at USD 83.41 billion in 2024 and is expected to expand around USD 129.14 billion by 2033, with a CAGR of 4.97% from 2024 to 2033. The market is ...
All positive (IHC 3+) and doubtful (IHC 2+) cases were screened by fl uorescence in situ hybridization (FISH). Patients with HER2 gene amplification, normal left ventricular ejection fraction ...
By analyzing ERBB2 mRNA expression data, researchers identified a group of HER2-negative patients with poor outcomes and potential markers of treatment resistance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results